Unknown

Dataset Information

0

Rebound activation of 5-HT neurons following SSRI discontinuation.


ABSTRACT: Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling discontinuation syndrome, the mechanism of which is surprisingly little investigated. Here we determined the effect on 5-HT neurochemistry of discontinuation from the SSRI paroxetine. Paroxetine was administered repeatedly to mice (once daily, 12 days versus saline controls) and then either continued or discontinued for up to 5 days. Whereas brain tissue levels of 5-HT and/or its metabolite 5-HIAA tended to decrease during continuous paroxetine, levels increased above controls after discontinuation, notably in hippocampus. In microdialysis experiments continuous paroxetine elevated hippocampal extracellular 5-HT and this effect fell to saline control levels on discontinuation. However, depolarisation (high potassium)-evoked 5-HT release was reduced by continuous paroxetine but increased above controls post-discontinuation. Extracellular hippocampal 5-HIAA also decreased during continuous paroxetine and increased above controls post-discontinuation. Next, immunohistochemistry experiments found that paroxetine discontinuation increased c-Fos expression in midbrain 5-HT (TPH2 positive) neurons, adding further evidence for a hyperexcitable 5-HT system. The latter effect was recapitulated by 5-HT1A receptor antagonist administration although gene expression analysis could not confirm altered expression of 5-HT1A autoreceptors following paroxetine discontinuation. Finally, in behavioural experiments paroxetine discontinuation increased anxiety-like behaviour, which partially correlated in time with the measures of increased 5-HT function. In summary, this study reports evidence that, across a range of experiments, SSRI discontinuation triggers a rebound activation of 5-HT neurons. This effect is reminiscent of neural changes associated with various psychotropic drug withdrawal states, suggesting a common unifying mechanism.

SUBMITTER: Collins HM 

PROVIDER: S-EPMC11319583 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rebound activation of 5-HT neurons following SSRI discontinuation.

Collins Helen M HM   Gullino L Sophie LS   Ozdemir Dersu D   Lazarenco Caroline C   Sudarikova Yulia Y   Daly Elizabeth E   Pilar Cuéllar Fuencisla F   Pinacho Raquel R   Bannerman David M DM   Sharp Trevor T  

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20240412 10


Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling discontinuation syndrome, the mechanism of which is surprisingly little investigated. Here we determined the effect on 5-HT neurochemistry of discontinuation from the SSRI paroxetine. Paroxetine was administered repeatedly to mice (once daily, 12 days versus saline controls) and then either continued or discontinued for up to 5 days. Whereas brain tissue levels o  ...[more]

Similar Datasets

2025-09-10 | GSE294867 | GEO
| S-EPMC7591481 | biostudies-literature
2023-08-30 | GSE203603 | GEO
| S-EPMC11258272 | biostudies-literature
| S-EPMC10394255 | biostudies-literature
| S-EPMC4394017 | biostudies-literature
| S-EPMC10561722 | biostudies-literature
| PRJNA1251882 | ENA
2024-06-19 | MSV000095087 | MassIVE
| S-EPMC2927054 | biostudies-literature